Myocardial Infarction News and Research

RSS

Drug eluting stents: New elements in the debate

Results announced at the 2006 ESC meeting in Barcelona questioned the long-term safety of drug eluting stents (DES) and sparked intense discussion.

31 Aug 2008

Best use of drug-eluting stents: When should they be avoided?

Compared with bare metal stents, drug-eluting stents substantially reduce the risk of angiographic and clinical recurrence but do not affect mortality or the short term or long term risk of myocardial infarction.

31 Aug 2008

DES in diabetic patients

The issue of using or not using DES in patients with diabetes will be debated between Professor Wijns, who discourages DES and Professor Silber, who feels that they should be used.

31 Aug 2008

The BEAUTIFUL study: Ivabradine and the reduction of cardiovascular events

The results of the much awaited BEAUTIFUL (morBidity-mortality EvAlUaTion of the If inhibitor ivabradine in patients with CAD and left ventricULar dysfunction) trial have shown that coronary artery disease (CAD) patients with left ventricular dysfunction (LVD) and a heart rate more than 70 bpm have a significantly higher risk of cardiovascular death and other cardiovascular events and in these patients (heart rate above 70 bpm) treatment with ivabradine further reduces the risk of the most important coronary events such as fatal and non-fatal myocardial infarction and coronary revascularisation by one third, even when these patients are already receiving optimal therapy.

31 Aug 2008

Global study shows Telmisartan reduces outcome of cardiovascular death, heart attack or stroke

An international study led by Canadian researchers has found that telmisartan, a medication used to lower blood pressure, reduced the outcome of cardiovascular death, heart attack or stroke in people who are unable to tolerate a widely available and effective standard treatment.

31 Aug 2008

Patients discontinuing statin medication following an acute myocardial infarction risk death

Patients discontinuing statin medication following an acute myocardial infarction (AMI) increase their risk of dying over the next year, say researchers at McGill University and the McGill University Health Centre (MUHC). Their study was published in a recent issue of the European Heart Journal.

27 Aug 2008

Amgen announces positive results for Denosumab postmenopausal osteoporosis trial

Amgen has announced findings from the pivotal fracture trial evaluating its RANK Ligand inhibitor, denosumab, in the treatment of postmenopausal osteoporosis.

27 Jul 2008

Study shows emergency physicians have good first instincts in diagnosing heart attacks

A study out of Wake Forest University Baptist Medical Center demonstrates emergency room doctors are correctly identifying patients who are having a heart attack, even when laboratory tests haven't yet confirmed it.

24 Jul 2008

Coronary heart disease linked to problems with reasoning, vocabulary and verbal fluency

Coronary heart disease is associated with a worse performance in mental processes such as reasoning, vocabulary and verbal fluency, according to a study of 5837 middle-aged Whitehall civil servants. The study also found that the longer ago the heart disease had been diagnosed, the worse was the person's cognitive performance and this effect was particularly marked in men.

22 Jul 2008

EpiCept and GNI partner to develop anti-viral hepatitis drug in Asia

GNI Ltd and EpiCept Corporation have announced that they have reached agreement to develop a new therapeutic drug, EP1013, in Asia, Australia, and New Zealand, for late-stage viral infection-induced hepatitis. EpiCept will retain the rights in the rest of the world. GNI’s wholly owned subsidiary, Shanghai Genomics, will start preparation for pre-IND and clinical development in China immediately.

17 Jul 2008

Diabetes could be a hidden condition for heart disease patients

Researchers at the University of Warwick have discovered diabetes could be a hidden condition for some patients with coronary heart disease.

15 Jul 2008

Insulin suppresses receptors that cause cascade of inflammation

Researchers at the University at Buffalo -- the first to identify the anti-inflammatory and cardioprotective properties of insulin -- now have discovered one pathway through which the hormone produces this effect.

13 Jul 2008

Novel approach shows potential to become an emergency treatment for heart attack patients

Researchers at The Children's Hospital of Philadelphia have manipulated cell activity that occurs during the interruption of blood flow to strongly protect heart tissue in animal studies. The finding has the potential to become an emergency treatment for heart attack patients, particularly since already existing drugs might be pressed into service to produce the protective effects.

10 Jul 2008

Pregnancy increases risk of acute myocardial infarction

Although acute myocardial infarction (AMI) is rare in women of child-bearing age, pregnancy can increase a woman's risk of heart attack 3- to 4-fold, according to a study published in the July 15, 2008, issue of the Journal of the American College of Cardiology.

8 Jul 2008

Queensland ambulance officers save lives with clot busting drug treatment

In February this year paramedics in Queensland became the first in Australia to provide potentially lifesaving drugs to heart attack victims as part of a research project funded by the Queensland Ambulance Service (QAS).

25 Jun 2008

Drug-releasing coronary artery stent use linked with decrease in procedures to unblock coronary arteries

The widespread adoption of the use of drug-releasing coronary artery stents into routine practice is associated with a decrease in the need for repeat procedures to unblock coronary arteries and also do not appear to increase the risk of death, compared to bare-metal stents, according to a study in the June 25 issue of JAMA, the Journal of the American Medical Association

24 Jun 2008

Nearly one in five patients experiences chest pain one year after having a heart attack

One of the main goals of in-hospital treatment and outpatient care after heart attack is to relieve angina (or episodic chest pain), according to background information in the article. The prevalence and treatment of chest pain one year after heart attack are largely unknown.

24 Jun 2008

Myocardial Infarction News and Research

Drug eluting stents: New elements in the debate

Best use of drug-eluting stents: When should they be avoided?

DES in diabetic patients

The BEAUTIFUL study: Ivabradine and the reduction of cardiovascular events

Global study shows Telmisartan reduces outcome of cardiovascular death, heart attack or stroke

Patients discontinuing statin medication following an acute myocardial infarction risk death

Amgen announces positive results for Denosumab postmenopausal osteoporosis trial

Study shows emergency physicians have good first instincts in diagnosing heart attacks

Coronary heart disease linked to problems with reasoning, vocabulary and verbal fluency

EpiCept and GNI partner to develop anti-viral hepatitis drug in Asia

Diabetes could be a hidden condition for heart disease patients

Insulin suppresses receptors that cause cascade of inflammation

Novel approach shows potential to become an emergency treatment for heart attack patients

Pregnancy increases risk of acute myocardial infarction

Queensland ambulance officers save lives with clot busting drug treatment

Drug-releasing coronary artery stent use linked with decrease in procedures to unblock coronary arteries

Nearly one in five patients experiences chest pain one year after having a heart attack

Hedgehog signaling is critical for maintenance of the adult coronary vasculature

Like father like son - history of heart attacks in the family

Lower incomes and lower education levels tied to higher death rates after heart attack

Improving healthcare sustainability through carbon data

Managing vibration in IVF laboratories

A New Approach to Preventing Bladder Cancer Recurrence

Latest News